PharmChem, Inc. common stock is traded on the OTC/Pink Sheets under the symbol ’PCHM.PK’. On March 26, 2004, the Company filed Form 15 under Rule 12g-2 of the 1934 Securities Exchange Act, whereby all reports required to be filed by Section 13(a) - including Forms 10-K, 10-Q & 8-K - are immediately suspended. As a result, the Company does not submit financial and other reports to the Securities and Exchange Commission.

Our CUISP number is 717133

Our Transfer Agent is

Phone: (503) 227 2950 Fax: (503) 227 6874

PharmChem, Inc. Company Contacts: 

Main Number: 855-458-4100

Joe Halligan (CEO)
David Lattanzio (CFO & Director)
Shana Veale (VP & Controller)
Kerri Wagner (President PharmChek Division)

2016 Letter to Stockholders 2015 Letter to Stockholders 2014 Letter to Stockholders 2013 Letter to Stockholders 2012 Letter to Stockholders 2010 Letter to Stockholders 2004 Special Meeting of Stockholders